ClinicalTrials.Veeva

Menu

Coronary and Structural Interventions Ulm - Transcatheter Mitral Valve Repair (CSI-Ulm-TMVR)

U

University of Ulm

Status

Completed

Conditions

Mitral Valve Regurgitation

Treatments

Device: CE certified mitral valve repair systems

Study type

Interventional

Funder types

Other

Identifiers

NCT03104660
CSI-Ulm-TMVR

Details and patient eligibility

About

To evaluate the long-term results after transcatheter mitral valve repair

Full description

Patients with transcatheter mitral valve repair are followed for 10 years to demonstrate efficacy and safety.

Enrollment

355 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mitral valve regurgitation
  • transcatheter mitral valve repair

Exclusion criteria

  • no written informed consent

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

355 participants in 1 patient group

CE certified mitral valve repair systems
Experimental group
Description:
CE certified transcatheter mitral valve repair systems
Treatment:
Device: CE certified mitral valve repair systems

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems